You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》大摩:藥明康德(02359.HK)首季盈利勝預期 評級「增持」
摩根士丹利發表報告指,藥明康德(02359.HK)(603259.SH)今年首季收入及純利分別爲84.74億元人民幣(按年增71.2%)及16.43億元人民幣(按年增9.5%),與該行預期相符,並超出預期的12.7%。 該行表示,公司首季業務表現令該行對公司今年收入增長65%至70%的指引感信心。 該行表示,由於管理層預計化學收入將於今年翻倍,故計劃將在去年成立2,000平方米的AppTec產能提升至70%。該行指,監於公司首季業績表現、明確的全年指引、及近期股價回落,強烈重申其評級爲「增持」,A股目標價爲174元人民幣。(ca/k) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account